Cefditoren Pivoxil – Oral products
Additional FDA-identified interpretive criteria
Minimum Inhibitory Concentrations (mcg/mL) | Disk Diffusion (zone diameter in mm) | |||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Streptococcus pneumoniae | 0.25 | >0.50 | - | - | - | |
Haemophilus influenzae and parainfluenzae | 0.25 | >0.50 | - | - | - | |
Streptococcus spp β- Hemolytic Group | - | - | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant